SAN DIEGO--(BUSINESS WIRE)--Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest ...

Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study Before HCT, 88 patients met morphologic criteria for complete remission (CR), ...

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial Invivoscribe Inc., a ...

Although established more than 30 years ago, the field of flow cytometry continues to grow and advance. It remains an indispensable tool for clinicians and researchers. The “Northwest Regional ...

Technological change is often driven by the needs of people. Flow cytometry is no different. The designs of instruments and processing techniques are evolving to meet the needs of researchers and drug ...

The last decade has seen a revolution in cancer immunotherapy. The demand from doctors, researchers, and pharmaceutical companies for more precise results with high sensitivity and high-quality ...

Almost every industry has discovered ways in which nanomaterials can improve the functionality of their products. While useful, nanomaterials are often considered to be uncharted territories in terms ...

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company ...